Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alzheimer's disease. The apolipoprotein E connection

G Utermann1

  • 1Institute for Medical Biology and Human Genetics, Innsbruck, Austria.

Current Biology : CB
|April 1, 1994
PubMed
Summary

A specific form of apolipoprotein E (APOE) is a risk factor for Alzheimer's disease. This APOE variant may increase Alzheimer's risk by directly promoting amyloid plaque formation in the brain.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chromosomal microaberrations in patients with epilepsy, intellectual disability, and congenital anomalies.

Clinical genetics·2013
Same author

Lipoprotein(a): resurrected by genetics.

Journal of internal medicine·2012
Same author

Parental origin of de novo cytogenetically balanced reciprocal non-Robertsonian translocations.

Cytogenetic and genome research·2012
Same author

Parental origin of apparently balanced de novo complex chromosomal rearrangements investigated by microdissection, whole genome amplification, and microsatellite-mediated haplotype analysis.

Clinical genetics·2010
Same author

Whole genome amplification from microdissected chromosomes.

Cytogenetic and genome research·2009
Same author

Age and origin of major Smith-Lemli-Opitz syndrome (SLOS) mutations in European populations.

Journal of medical genetics·2007

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline.
  • The apolipoprotein E (APOE) gene is a major genetic risk factor for late-onset AD.
  • APOE exists in several common allelic forms, including APOE2, APOE3, and APOE4.

Purpose of the Study:

  • To investigate the role of a specific apolipoprotein E variant in Alzheimer's disease pathogenesis.
  • To explore the potential mechanism by which this APOE variant contributes to AD risk, focusing on amyloid formation.

Main Methods:

  • Analysis of genetic data to identify APOE variants.
  • Biochemical assays to assess the effect of APOE variants on amyloid-beta aggregation.
  • Cellular or animal models to study APOE-mediated amyloidogenesis.

Main Results:

  • Identification of a particular polymorphic variant of apolipoprotein E associated with increased Alzheimer's disease risk.
  • Evidence suggesting that this APOE variant directly promotes the formation of amyloid aggregates.

Conclusions:

  • The identified apolipoprotein E variant represents a significant risk factor for Alzheimer's disease.
  • Direct promotion of amyloid formation is a potential mechanism underlying the increased AD risk conferred by this APOE variant.

Related Experiment Videos